In silico screening of potent inhibitors against COVID-19 key targets from a library of FDA-approved drugs

Coronavirus disease (COVID-19) is an emerging pandemic that threatens the world since the early days of 2020. Development of vaccines or new drugs against COVID-19 comprises several stages of investigation including efficacy, safety, and approval studies. A shortcut to this delicate pathway is compu...

Descripción completa

Detalles Bibliográficos
Autores principales: Elmorsy, Mohammad A., El-Baz, Ahmed M., Mohamed, Nashwa H., Almeer, Rafa, Abdel-Daim, Mohamed M., Yahya, Galal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475441/
https://www.ncbi.nlm.nih.gov/pubmed/34562220
http://dx.doi.org/10.1007/s11356-021-16427-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475441/
https://www.ncbi.nlm.nih.gov/pubmed/34562220
http://dx.doi.org/10.1007/s11356-021-16427-4

Ejemplares similares